CMS certification 453300
Cook Childrens Medical Center
801 Seventh Avenue, Fort Worth, TX 76104
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: Oct 2024 – Sep 2025.
Not reported for this hospital
CMS had too few cases here to publish results for deaths, complications, infections caught in the hospital, readmissions and return visits. That is common at small, rural and specialty hospitals, and says nothing either way about quality.
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.7M
- 2020 $2.5M
- 2021 $2.4M
- 2022 $2.2M
- 2023 $1.1M
- 2024 $1M
- 2025 $598,006
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $38,892 | 4 |
| Speaking, teaching and other services | $14,910 | 21 |
| Space rental and facility fees | $8,645 | 24 |
| Grants | $5,500 | 2 |
| Debt forgiveness | $31 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | $165,052 | 3 |
| DiaSorin Molecular LLC | $82,095 | 2 |
| Novo Nordisk AS | $50,861 | 16 |
| Novartis Pharmaceuticals Corporation | $47,505 | 9 |
| Takeda Pharmaceuticals U.S.A., Inc. | $46,986 | 18 |
| Aurinia Pharma U.S., Inc. | $33,180 | 4 |
| Eli Lilly and Company | $31,869 | 1 |
| MED-EL Corporation | $27,270 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| DSM Starfish (DSM-DD23-003) DiaSorin Molecular LLC | $79,595 |
| A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 18 Years and Older With A… VERTEX PHARMACEUTICALS INCORPORATED | $74,491 |
| A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis VERTEX PHARMACEUTICALS INCORPORATED | $59,624 |
| NN7415-4616 Novo Nordisk AS | $44,481 |
| A PHASE 2, PROSPECTIVE, INTERVENTIONAL, OPEN-LABEL, MULTI-SITE, EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY AND TOLERABILITY OF TAK-935 (OV935) AS… Takeda Pharmaceuticals U.S.A., Inc. | $40,382 |
| A MASTER PROTOCOL FOR A PHASE 3, MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF MIRIKIZUMAB IN C… Eli Lilly and Company · NCT04844606 | $31,869 |
| A Phase 1, First-in-human Study of Safety, Tolerability, and Pharmacokinetics of VX-828 VERTEX PHARMACEUTICALS INCORPORATED | $30,937 |
| An Open-label, Multi-center, Phase IV, Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizum… Novartis Pharmaceuticals Corporation | $28,058 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Cook Childrens Medical Center
Does Cook Childrens Medical Center have an emergency room?
Yes. CMS lists emergency services at Cook Childrens Medical Center.
Does Cook Childrens Medical Center receive money from drug and device companies?
Drug and device makers reported $598,006 in payments to Cook Childrens Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.